Deadline: All Abstracts are due electronically by July 17, 2024.
Suggested Guidelines for the Abstract Submission
Provide information for each section listed below in the body of your abstract:
- Title
- Authors and organizational affiliations (with email for contact author)
- Introduction and overall goal
- Specific aims
- Rationale and background
- Methods and materials
- Results
- Discussion and conclusion
- References (optional)
References Format
If there are citations, list references numerically at the end of the abstract in the order by which they were cited in the text.
Example: Cooperberg, MR, Broering, JM, Carroll PR, et. al. Time trends and local variation in primary treatment of localized prostate cancer, Journal of Clinical Oncology 2010 (28): 1117-1123.
Length, Font, and Format
The abstract should not exceed one page (single spaced). Use font no smaller than “Times New Roman 12” or “Arial 11”, and margins of at least 0.5 in.
General Content and Guidelines
- The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection.
- Content must be restricted to pure science, technology, methodology, materials and/or operational characteristics of devices. Product and company names should be included only to identify the technology or methodology used, but not to promote proprietary interests.
- All research must conform to generally accepted standards of experimental design, data collection and analysis.
- The submitted abstract does not have to be an original submission and can be an encore abstract (i.e., it can have been submitted elsewhere)
Review Criteria
- Is this research novel?
- Does this research advance knowledge, and/or improve diagnostic information and/or capabilities?
- Does it produce new data or analysis of interest and relevance to the research or clinical community?
- Is the data substantive and not just implied? Does it describe a research accomplishment, rather than work yet to be done?
- Is comprehensive statistical analysis relevant and applied?
- Are recommendations involving clinical medicine based on evidence that is accepted as adequate justification for indications and contraindications in patient care?
- What is the impact factor of this work? The abstract should address how the proposed study is expected to impact research or patient care.
- Is the abstract biased in favor of a particular product or company? Evident bias is grounds for rejection. (Use of a particular company’s products or equipment does not represent bias. Non-data- based statements of comparative superiority, however, would be considered biased.)
Abstract Publication, Competition and Presentation
If your abstract is selected, it will be published electronically on the dedicated Summit 2024 website pages of the AdMeTech Foundation.
All abstracts will undergo a peer review, will be scored and take part in a competition. The authors of the top three abstracts will have an opportunity to have presentations of their work (3 minutes each) during the main scientific program on Friday, October 8, 2024.
Winners of the top three abstracts will be announced on the dedicated AdMeTech Foundation’s website pages, social media and dedicated newsletters. They will also receive free registrations for Summit 2025.
Videos for Winning Abstracts
If your abstract wins one of the top three spots in the competition, you will be required to provide a 3-minute video of your presentation by August 19, 2024. An .mp4 file is preferred. Prior to its submission, please upload your video into Google Drive and then share it as the editable file to Emma Couillard at emma.couillard@admetechfoundation.org. This way, your video can be downloaded and professionally edited, if needed. If you need any assistance with or have questions about preparing your video, please contact Emma Couillard by email as above.
Failure to Present
Submission of an abstract is considered a commitment to present the poster during main scientific program, if it is accepted and wins one of the top three places. Failure to present a poster may jeopardize future submissions by the same author.
Submission
Please send abstract in a PDF format to faina.shtern@admetechfoundation.org, with the Subject Line “2024 Summit Abstract” by July 17, 2024.
Registration is Required Prior to Review of Your Abstract
When you submit your abstract, you will be provided access to a discounted (50%) registration fee. Your registration is required prior to review of your abstract.
If you are experiencing financial hardship, please request free access to the event.
For assistance with the offered 50% discounted or free registrations in connection with the abstract submissions, please contact Emma Couillard by email at emma.couillard@admetechfoundation.org.